Time in target range of fasting blood glucose ranges defined by WHO and ADA guidelines and cardiorenal Risk: Insights from two cohorts [0.03%]
世卫组织和美国内分泌医师协会指南界定的空腹血糖目标范围内的时间与心血管和肾脏风险：来自两个队列的启示
Jiaheng Zhang,Haibao Xu,Yezhou Liu et al.
Jiaheng Zhang et al.
Aims: Through the utilization of the time in target range (TTR), our study aims to reassess the differential risks of cardiorenal diseases associated with inconsistent pre-diabetes criteria, as defined by the World Health...
Comparison of maternal characteristics and clinical parameters in Thai pregnant women with and without gestational diabetes mellitus [0.03%]
泰国妊娠期糖尿病患者与非妊娠期糖尿病患者的母体特征及临床参数的比较
Amanee Hanafee,Sarocha Suthon,Saranya Innang et al.
Amanee Hanafee et al.
Objective: Gestational Diabetes Mellitus (GDM) poses a significant risk to maternal and fetal health, yet remains underrecognized in Southeast Asia, particularly in Thailand. ...
Sex differences in the risk of vascular and non-vascular complications in type 2 diabetes: the Fukuoka Diabetes Registry [0.03%]
2型糖尿病患者血管和非血管并发症风险的性别差异：福冈糖尿病注册中心数据研究
Toshiaki Ohkuma,Masanori Iwase,Taiki Higashi et al.
Toshiaki Ohkuma et al.
Aims: There is recent evidence for sex-based differences in complications associated with type 2 diabetes, with women showing a lower risk of macrovascular complications than men. However, sex differences in the risks of ...
Associations of age at T2D detection with hemoglobin A1c in a national inception cohort of U.S. Veterans with diabetes [0.03%]
美国退伍军人糖尿病国家初始队列中T2D检测年龄与血红蛋白A1c的关系
Sanja Avramovic,Xumin Li,Daniel A Enquobahrie et al.
Sanja Avramovic et al.
Objective: To investigate associations of age at type 2 diabetes (T2D) detection with HbA1c. Research design and methods: We examined a...
The association of weight status with glycemic control, diabetes related complications and anti-hyperglycemic medication use in patients with type 2 diabetes mellitus: The results of the Australian National Diabetes Audit (ANDA) 2015-2022 [0.03%]
体重状态与2型糖尿病患者血糖控制、糖尿病相关并发症和降糖药物使用之间的关系：澳大利亚国家糖尿病审计（ANDA）2015-2022年结果报告
N Szwarcbard,A Xiang,D Gasevic et al.
N Szwarcbard et al.
Aims: Type 2 diabetes has reached pandemic proportions; and obesity is considered one of its main drivers. We investigated the association of weight status with glycemic control, diabetes related complications and anti-hy...
Trends of lower-limb complications in patients with type 2 diabetes mellitus during the COVID-19 pandemic [0.03%]
新冠肺炎疫情期间2型糖尿病下肢并发症的变化趋势分析
Ivan Y Luu,Alexander T Hong,Forest Lin et al.
Ivan Y Luu et al.
Aims: The long-term impact of the COVID-19 pandemic on lower limb complications remains unclear. We aimed to assess the effect of the COVID-19 pandemic on the prevalence of diabetic foot ulcers (DFUs) and the incidence of...
Screening, prevalence, and burden of chronic kidney disease in people with type 2 diabetes managed by endocrinologists: A nationwide cross-sectional study [0.03%]
内分泌科管理的2型糖尿病人群的慢性肾脏病筛查、患病率和疾病负担：一项全国横断面研究
José Ignacio Martínez-Montoro,Jose Juan Aparicio-Sánchez,Belén Pimentel et al.
José Ignacio Martínez-Montoro et al.
Aims: To describe and characterize chronic kidney disease (CKD) prevalence, screening practices and associated burden on people with type 2 diabetes (T2D) managed by endocrinologists. ...
Hepatic steatosis with significant fibrosis is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes [0.03%]
1型糖尿病患者肝脂肪变性伴显著纤维化与颈动脉斑块无创评价指标相关性研究
Maria Claro,Clara Viñals,Marga Giménez et al.
Maria Claro et al.
Aims: Evaluate the association between metabolic dysfunction-associated steatotic liver disease (MASLD) scores and preclinical atherosclerosis in type 1 diabetes (T1D). ...
Comparative outcomes of adding SGLT2 inhibitors versus incretin-based therapies to insulin in type 2 diabetes [0.03%]
在胰岛素治疗的基础上加用钠-葡萄糖共转运体2抑制剂与肠促胰素类药物治疗2型糖尿病的比较结局
Fu-Shun Yen,James Cheng-Chung Wei,Yu-Han Huang et al.
Fu-Shun Yen et al.
Aims: To compare the risks of cardiovascular events and major microvascular complications associated with adding sodium-glucose cotransporter-2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP-4) inhibitors or glucag...
Pregestational and gestational diabetes mellitus and risk of postpartum kidney disease: A retrospective cohort study [0.03%]
妊娠前期和妊娠期糖尿病与产后肾脏疾病风险的关系：一项回顾性队列研究
Amy Backal,Swathi Vasudevan,Rachel Lee et al.
Amy Backal et al.
Background: Globally, rates of Pregestational (PGDM) and Gestational Diabetes Mellitus (GDM) are rising, but how they affect the risks of kidney disease in the postpartum period remains poorly understood. ...